InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Joseph Monahan, Chief Scientific Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 11 open-market SEC Form 4 transactions: 0 purchases worth $0 and 11 sales worth $1.7M, reported from Feb 9, 22 to Oct 23, 23. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 23, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 6.0K | $5.08 | $30K |
| Aug 21, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 6.0K | $7.32 | $44K |
| Jun 20, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 6.0K | $10.28 | $62K |
| Mar 3, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 16.0K | $12.63 | $203K |
| Mar 2, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 14.8K | $12.37 | $183K |
| Feb 15, 23 | ACRSAclaris Therapeutics, Inc. | SELL | 5.0K | $13.06 | $65K |
| Dec 15, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 5.0K | $15.88 | $79K |
| Oct 17, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 5.0K | $15.98 | $80K |
| Apr 18, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 30.0K | $16.28 | $488K |
| Mar 10, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 27.2K | $15.71 | $427K |
| Feb 9, 22 | ACRSAclaris Therapeutics, Inc. | SELL | 383 | $12.68 | $5K |